Accelerate Innovation.
Advance Your Molecule
with Confidence.
Discovery. Development. Manufacturing.
One Trusted Integrated CRDMO Partner
Book a meeting at CPHI
What thirty minutes at our stand actually gets you
Accelerate Development Timelines
Usually: Six weeks after the show you are still waiting on a feasibility view, and the programme has not moved.
With Aurigene: 6-12 months for complex small-molecule API transfer 9 months for biologics.
Integrated Development & Manufacturing
Usually: Drug substance and drug product sit with different suppliers - managing the seam between them becomes your job, not theirs.
With Aurigene: One partner from target identification to commercial supply, under one contract and one quality system.
Single Quality System
Usually: Each supplier runs its own QMS - reconciling them and scheduling audits is your overhead, not theirs.
With Aurigene: DCGI, NGCMA, GLP and USFDA acceleration under a single quality framework across all sites. Less duplication, smarter resources, sustainable operations.
Peptide Expertise
Usually: Most CDMOs top out at gram scale for complex peptides - commercial volume means switching supplier and revalidating.
With Aurigene: SPPS/ LPPS/ Fragment-based approach/ TAPS from milligram to commercial tonnage. mPEGs, PEGylation, PROTAC and cryogenic reactions all in-house.
Clinical-to-Commercial Scale-Up
Usually: Capacity is "available" right up until you ask for a firm date against your timeline.
With Aurigene: 4,100 m³ across 1, 250 reactors; 2,100 MT API per year; 20 KL biologics DS - India, UK and Mexico.
Discovery to commercial supply, under one roof
Small Molecule CRDMO
Route scouting and process development through GMP API and commercial supply, including potent and high-containment work.
Peptide Development & Manufacturing
Solid-phase and solution-phase peptide synthesis, scaled to commercial volumes - capacity most mid-tier CDMOs cannot offer.
Biologics CRDMO
Antibody discovery, cell line development, upstream and downstream processing, GMP drug substance and fill finish across four modalities.
Integrated Development Support
Discovery chemistry and biology at one end, GLP toxicology, CMC regulatory and lifecycle support at the other - the parts most CDMOs make you source separately.
Meet the team who own and support your program
Pick a day, we will bring the right person
Resources
Questions we get asked at the stand
See you at Booth No. 5D18
CPHI Milan, 06-08 October 2026.